PrevahexCHX has efficacy of over 5.0 log10 reduction against several multidrug-resistant microorganisms, the pathogens responsible for some of the most difficult-to-treat HAIs facing clinicians today. In contrast, the market leading standard transparent thin film dressing offers no antimicrobial protection to patients.
Versus Drug-Resistant Pathogens
Source: Test Conducted at Third Party GLP Laboratory, Data on File, Entrotech Life Sciences Inc, San Francisco. Tegaderm is a registered trademark of 3M
PrevahexCHX demonstrate rapid onset of action starting at day 1 and continuing through day 7, thus dramatically outperforming other competitive antimicrobial dressings which can take several days to demonstrate significant efficacy.
In vitro Antimicrobial Effects of Chlorhexidine Diacetate versus Chlorhexidine Free Base Dressings.
George J. Holinga, PhD, and James E. McGuire, BS
entrotech life sciences inc., San Francisco, California
Published in the Journal of Wound Care, Volume 29. Number 5. May 2020.